Education
About Us
Working with TipRanks
Follow Us
PuraPharm Corp. Ltd. (HK:1498)
:1498
RESEARCH TOOLSreports
1498 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.43 - HK$0.85
Previous CloseN/A
Volume23.50K
Average Volume (3M)100.67K
Market Cap
HK$193.52M
Enterprise ValueHK$901.21M
Total Cash (Recent Filing)HK$12.79M
Total Debt (Recent Filing)HK$363.76M
Price to Earnings (P/E)―
Beta0.34
Next Earnings
Sep 02, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 31, 2017Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding395,897,280
10 Day Avg. Volume158,900
30 Day Avg. Volume100,666
Financial Highlights & Ratios
PEG Ratio1.30
Price to Book (P/B)1.96
Price to Sales (P/S)0.00
P/FCF Ratio11.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PuraPharm Corp. Ltd. News
PremiumCompany Announcements
PuraPharm Faces Compliance Challenges After Director Resignation
PremiumCompany Announcements
PuraPharm Announces Board of Directors and Roles
PremiumCompany Announcements
PuraPharm Announces Lapse of Disposal Agreement
PremiumCompany Announcements
PuraPharm Appoints Dr. Kam Biu Tsoi as Executive Director
PremiumCompany Announcements
PuraPharm Announces Board Composition and RolesPremiumCompany Announcements
PuraPharm Updates Nomination Committee Terms to Enhance Governance
PremiumCompany Announcements
PuraPharm Announces Disposal of Accounts Receivables in HK$15 Million DealPremiumCompany Announcements
PuraPharm Corporation Announces Successful AGM Resolutions1498 FAQ
What was PuraPharm Corp. Ltd.’s price range in the past 12 months?
PuraPharm Corp. Ltd. lowest stock price was HK$0.43 and its highest was HK$0.85 in the past 12 months.
What is PuraPharm Corp. Ltd.’s market cap?
PuraPharm Corp. Ltd.’s market cap is HK$193.52M.
When is PuraPharm Corp. Ltd.’s upcoming earnings report date?
PuraPharm Corp. Ltd.’s upcoming earnings report date is Sep 02, 2025 which is in 59 days.
How were PuraPharm Corp. Ltd.’s earnings last quarter?
PuraPharm Corp. Ltd. released its earnings results on Mar 31, 2025. The company reported -HK$0.042 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.042.
Is PuraPharm Corp. Ltd. overvalued?
According to Wall Street analysts PuraPharm Corp. Ltd.’s price is currently Overvalued.
Does PuraPharm Corp. Ltd. pay dividends?
PuraPharm Corp. Ltd. pays a Annually dividend of HK$0.019 which represents an annual dividend yield of N/A. See more information on PuraPharm Corp. Ltd. dividends here
What is PuraPharm Corp. Ltd.’s EPS estimate?
PuraPharm Corp. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PuraPharm Corp. Ltd. have?
PuraPharm Corp. Ltd. has 395,897,280 shares outstanding.
What happened to PuraPharm Corp. Ltd.’s price movement after its last earnings report?
PuraPharm Corp. Ltd. reported an EPS of -HK$0.042 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5%.
Which hedge fund is a major shareholder of PuraPharm Corp. Ltd.?
Currently, no hedge funds are holding shares in HK:1498
PuraPharm Corp. Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-31.50%
12-Months-Change
Fundamentals
Return on Equity
-26.80%
Trailing 12-Months
Asset Growth
-15.19%
Trailing 12-Months
Company Description
PuraPharm Corp. Ltd.
PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Haveron, Oncozac, and Immuzac names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it provides modernized Chinese medicine services; and Chinese medical diagnostic services. The company sells its products to hospitals, healthcare institutions, and medicine practitioners, as well as operates an online store. It operates 43 Nong's clinics in Hong Kong and 1 Nong's clinic in Guangxi, China. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.
Technical Analysis
Extrawell Pharmaceutical Holdings Limited
―
China NT Pharma Group Co., Ltd.
―
Kontafarma China Holdings Ltd
―
Fusen Pharmaceutical Co., Ltd.
―
Huakang Biomedical Holdings Company Limited
―